Hong Kong Software Stock News

PCCW (SEHK:8) is back in focus after recent trading left the share price at HK$5.30, with total return over the past year rising 6.6% and the past 3 years showing a very large gain. Short term, PCCW’s share price has drifted lower, with the 7 day return down 2.1% and the year to date share price return down 4.3%. However, the 1 year and 3 year total shareholder returns of 6.6% and roughly 84.7% point to momentum that has been built over a longer stretch. Scan beyond PCCW’s recent 3 year surge...

Weichai Power approved an interim cash dividend of HK$0.5976 per H share for the six months to 30 June 2026. Shareholders also passed resolutions on revised sale caps for transactions with Shaanxi Automotive and confirmed changes to the board at the September extraordinary general meeting. Addition to the Hang Seng Index, combined with fresh board representation and updated related party sale arrangements, may reshape how investors view Weichai Power’s capital returns, governance structure...

Some of the losses seen by insiders who purchased HK$15.7m worth of HKC International Holdings Limited ( HKG:248...

Insiders who bought HK$9.69m worth of Good Fellow Healthcare Holdings Limited ( HKG:8143 ) stock in the last year...

Some Jolimark Holdings Limited ( HKG:2028 ) shareholders may be a little concerned to see that the Founder & Executive...

China Overseas Grand Oceans Group reported unaudited August 2026 data showing property contracted sales of RMB 2,348,000,000 and contracted gross floor area of 199,100 square meters, with year-on-year changes of 10.1% and a 2.0% decline respectively. For the first eight months of 2026, contracted sales reached RMB 24,421,000,000 and 2,094,100 square meters. Both metrics recorded double digit year-on-year growth, reflecting ongoing buyer demand for the developer’s projects. We will now...

Shanghai Henlius Biotech reported that China's Center for Drug Evaluation accepted its NDA for HLX14, a 120 mg denosumab biosimilar vial, targeting cancer related bone complications and unresectable giant cell tumor of bone in patients with mature skeletons. The HLX14 filing in China follows prior approvals of related products in the United States, Europe, the United Kingdom, and Canada, and points to a broader commercial push around denosumab biosimilars across oncology and osteoporosis...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Insiders who bought HK$34.9m worth of Kai Yuan Holdings Limited ( HKG:1215 ) stock in the last year recovered part of...

Shanghai Electric announced that it secured the EPC turnkey contract and a 25-year long-term service agreement for Unit 3 of the Sarawak Samalaju CCGT gas-fired power project in Malaysia, supplying all major equipment from its own manufacturing base. The deal gives Shanghai Electric end-to-end responsibility, from in-house turbine and generator production through to multi-decade maintenance. This concentrates both execution risk and potential long-term service revenue in a single overseas...

Vobile Group (SEHK:3738) moved into the spotlight after a subsidiary agreed to work with Ant Blockchain Technology to build a copyright large model for digital content in the AI era. Recent trading suggests interest is building again in Vobile Group, with a 1 day share price return of 12.67% and a 30 day share price return of 45.95% around the Ant Blockchain announcement. This comes even though the share price return year to date is down 22.44%, the 1 year total shareholder return has...

Readers hoping to buy Yip's Chemical Holdings Limited ( HKG:408 ) for its dividend will need to make their move...

Meitu has rolled out MVLAND Version 2.0 with a new Studio Mode that unifies music analysis, storyboarding, shot creation and post-editing into a single workflow for AI generated music videos. The focus on music first logic, precise shot level editing and a multi track editor indicates that Meitu is pushing into more professional grade, end to end video production tools that could matter for how its creative ecosystem earns money. We will now look at how Meitu's investment narrative could be...

China Longyuan Power Group reported August 2026 consolidated generation of 5,608,057 MWh, up 6.35% year on year, with wind output slightly higher and solar output rising 20.67%. Year to date generation to 31 August 2026 was 50,583,726 MWh, which was 1.31% lower than the same period in 2025. The sharp 20.67% rise in solar generation contrasted with a 5.76% year to date decline in wind output. This highlights how China Longyuan Power Group’s growing solar contribution is helping offset weaker...

China State Construction International Holdings announced a total dividend of $0.04 per share with an ex-dividend date that occurred on 16 September 2026, extending its pattern of bi-annual distributions and a payout ratio of 0.35 supported by reported profitability metrics. The steady dividend record and conservative payout approach indicate that China State Construction International Holdings is prioritising cash discipline and income predictability, which matters for investors weighing...

China Galaxy Securities (SEHK:6881) recently drew fresh attention after closing at HK$7.58. The share price has moved modestly over the past week, and longer term returns show a mix of gains and declines. Recent movement has been mixed for China Galaxy Securities, with a 1-day share price return of 0.53% and a 30-day share price return of 3.48%, set against a year-to-date share price decline of 27.32%. The 5-year total shareholder return of 126.53% points to much stronger long term momentum...

InSilico Medicine Cayman TopCo (SEHK:3696) reported that its AI-discovered drug rentosertib has progressed into Phase 3 clinical trials. New peer-reviewed studies on rentosertib indicate reversal of biological age in treated patients, based on multiple independent aging models. Global research collaborators are using rentosertib trials to build frameworks that embed aging biomarkers into idiopathic pulmonary fibrosis studies. The move of rentosertib into Phase 3, together with the reported...

Henderson Land Development recently drew attention after fresh analysis highlighted that its shares trade on a P/E ratio above both peer companies and the wider industry, prompting investors to reassess how the current market price aligns with the underlying property and development operations. A discounted cash flow model now suggests Henderson Land Development’s market valuation is well above its estimated intrinsic value, raising questions about how much future cash generation justifies...

Chinasoft International announced it won a RMB 35.5 million bid to build the Guangdong Industrial Robot and Smart Home Application Enablement Centre, extending its OpenHarmony based AI and IoT capabilities into Foshan’s large pan home furnishing manufacturing cluster. The project moves Chinasoft International from a pure technology service role toward operating an industry enablement platform that embeds its AI, device edge cloud and smart home expertise directly into a trillion RMB home...

Kingboard Laminates Holdings closed at HK$47.10 on Friday, up strongly over the past month even though the past week has been weak. The market came into this earnings print already paying a rich P/E of 33.8x, well above peers, so sentiment was leaning optimistic rather than cautious. The headline from these half year numbers is clear. Profitability has shifted sharply, with trailing net profit margin at 17.1% compared with 7.9% a year earlier and earnings over the past twelve months up 187%...

Xiaomi has seen its share price move sharply over recent years, and the question now is whether the current Hong Kong dollar price is justified by the cash flows the business can generate over time. With the stock recently closing at HK$26.40, investors are asking how much of the company’s cash flow story is already reflected in that number. Over the past 3 years, Xiaomi has delivered a 118.9% share price gain, which puts its current valuation under close scrutiny given the cash it is...

The market has barely flinched on NagaCorp, with the share price little changed over the past week even as fresh H1 2026 numbers put profitability in the spotlight. Net income of US$144.0m on US$293.7m in revenue keeps the business anchored in very high margin territory. That combination feeds straight into a low 5.9x P/E compared with Hong Kong hospitality peers that trade on much richer multiples. The key question for traders now is whether today’s muted move reflects a cool-headed focus on...

Shenguan Holdings came into this earnings season with a beaten up share price and a bargain label, trading around HK$0.25 while analysts see much higher value. The latest H1 2026 report undercuts that bargain story. Revenue sits at ¥455.957 million yet the business still posted a net loss of ¥44.863 million and basic earnings per share stayed in the red. For a stock priced on hope of a turnaround, another period of loss making operations keeps the spotlight firmly on profitability pressure...

GenFleet Therapeutics (Shanghai) closed at HK$25.9 after a choppy few months that left the stock down about 13% over 30 days and nearly 10% over 90 days. Today's headline is not about a sudden turnaround in profits. It is about whether investors accept a biotech story that is still deep in the red. The H1 2026 loss of C¥220.17 million and basic earnings per share of C¥0.59 in the red underline how early this commercial journey still is. What brings the longer-term view into focus is the...